The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention
EuroIntervention 2011;6:1085-1090.
Asmir I. Syed, MD; Itsik Ben-Dor, MD; Yanlin Li, MD; Sara D. Collins, MD; Rebecca Torguson, MPH; Kohei Wakabayashi, MD; Manuel A. Gonzalez, MD, MPH; Gabriel Maluenda, MD; Cedric Delhaye, MD; Loic Belle, MD; Michael A. Gaglia, Jr., MD, MSc; Zhenyi Xue, MS; Kimberly Kaneshige, BS; Nelson Bernardo, MD; Kenneth M. Kent, MD, PhD; William O. Suddath, MD; Lowell F. Satler, MD; Augusto D. Pichard, MD; Joseph Lindsay, MD; Ron Waksman*, MD
Department of Medicine, Division of Cardiology, Washington Hospital Center, Washington DC, USA
Aims: This study aimed to examine the strategy of hybrid percutaneous coronary intervention (PCI) –bare metal stent (BMS) and drug-eluting stent (DES)– versus exclusive DES implantation for